The Kingdom of Saudi Arabia and Rezolve AI Ink Pioneering MOU to Establish Global AI Market Leaders

The Kingdom of Saudi Arabia and Rezolve AI Ink Pioneering MOU to Establish Global AI Market Leaders
Dan Wagner, CEO and Chairman of Rezolve AI Limited and Saleh Al-Khabti, Deputy Minister of Investment Transactions for the KSA
  • Establishment of an AI Centre of Excellence in Saudi Arabia
  • Creation of Global Market Leaders

(Please Note on December 17, 2021, Rezolve AI entered into a definitive Business Combination Agreement (as amended and restated on June 16, 2023, the “Business Combination Agreement”) with Armada Acquisition Corp. I (NASDAQ: AACI), a publicly traded special purpose acquisition company, which is expected to close in H1 2024, subject to approval by Armada’s shareholders, the Registration Statement being declared effective by the SEC, and other customary closing conditions. Upon closing of the transaction, the combined company’s shares are expected to trade on the Nasdaq under the ticker symbol “ZONE”.)

LONDON, March 18, 2024 (GLOBE NEWSWIRE) — In a strategic move that highlights the Kingdom of Saudi Arabia’s commitment to technological advancement and economic growth, the Ministry of Investment of Saudi Arabia (MISA) has forged a groundbreaking partnership with Rezolve AI Limited. This collaboration is set to revolutionize the artificial intelligence (AI) landscape, establishing an AI Centre of Excellence in Saudi Arabia as a cornerstone of Vision 2030’s innovation and development goals.

Key Highlights of the Partnership:

• Establishment of an AI Centre of Excellence in Saudi Arabia: To serve as a hub for innovation, leveraging Rezolve AI’s unique technology to navigate and solve the industry’s pressing challenge of AI hallucinations, ensuring the creation of reliable and ethical AI solutions.

• Creation of Global Market Leaders: In partnership with the Ministry of Investment, the goal is to launch at least five AI ventures in diverse market sectors, funded and headquartered locally, each aspiring to become global market leaders. These ventures will leverage Rezolve’s cutting-edge AI Large Language Model (brainpowa) to foster innovation and ensure global leadership without succumbing to AI hallucinations.

The initiative is integral to Saudi Arabia’s strategic vision, positioning the Kingdom not just as a leader in AI technology but also as the foundation for global AI-driven companies. This underscores Saudi Arabia’s role as a nucleus for technological innovation and economic diversification.

The Ministry of Investment will facilitate the participation of leading public and private financial and corporate institutions to anchor and support Rezolve’s upcoming listing on NASDAQ. This demonstrates KSA’s commitment to being open for business and welcoming the next generation of global leaders, encouraging them to base their operations and Headquarters in the Kingdom.

At the signing ceremony in Riyadh last week, Saleh Al-Khabti, Deputy Minister of Investment Transactions for the KSA, and Dan Wagner, CEO and Chairman of Rezolve AI Limited, underscored the transformative potential of this partnership. It marks a significant milestone in Saudi Arabia’s journey toward becoming a global technology powerhouse, showcasing the Kingdom’s commitment to nurturing the growth of next-generation technology leaders on an international stage.

About Rezolve AI Limited

Rezolve is taking retailing into a new era of customer engagement with a proprietary mobile engagement platform. The Rezolve Platform is a powerful set of mobile commerce and engagement capabilities that provide mobile application vendors with a range of valuable commercial opportunities that can be realized without having to develop code, host operations or manage security. The Rezolve Inside SDK allows mobile application vendors to quickly deliver innovation for their consumers into existing or new mobile apps. Rezolve was founded in 2016, is headquartered in London, UK and has offices including: Shanghai, New Delhi, Taipei, Frankfurt, Madrid, Mexico City and Providence, RI, USA. (www.rezolve.com)

About Armada Acquisition Corp. I

Armada Acquisition Corp. I (Nasdaq: AACI) is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Armada was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Media contacts:

Ministry of Investment, Kingdom of Saudi Arabia:
InvestorCare@misa.gov.sa

Rezolve:
urmeekhan@rezolve.com
44-7576-094-040

Armada Acquisition Corp:
Mike Bishop Bishop IR, LLC mike@bishopir.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c01e8271-55cc-41e5-818e-e68133cdc513

GlobeNewswire Distribution ID 9064927

Women in the Digital Economy Fund: USAID, the Bill & Melinda Gates Foundation, and Partners Launch WiDEF

NEW YORK, N.Y., March 12, 2024 (GLOBE NEWSWIRE) — The Women in the Digital Economy Fund (WiDEF), a five-year $60.5 million investment to accelerate progress on closing the global gender digital divide, announces its first call for applications with recorded remarks from the United States Agency for International Development (USAID) Administrator Samantha Power.

Founded by USAID and the Bill & Melinda Gates Foundation—and first announced by U.S. Vice President Kamala Harris in Accra, Ghana in March 2023—WiDEF will now begin identifying, funding, and accelerating investment in proven solutions to close the gender digital divide.

​”The gender digital divide hinders development progress—ingraining existing inequities into the fabric of societies of the future, creating a self-perpetuating cycle that drives further disparities. We need a future in which women are empowered to participate as equal citizens in our increasingly digital world. We look forward to working together to achieve that vision,” said Samantha Power, Administrator, USAID.

“I’m proud of our support for the Women in the Digital Economy Fund. Overcoming the gender digital divide is crucial to unlock the potential of women in the digital era. By increasing women’s participation in digital technology, we’re aiming not just to change their status from consumers to creators and leaders; we’re working to forge a path to a future where everyone benefits,” said Anita Zaidi, President of the Gender Equality Division at the Bill & Melinda Gates Foundation.

This event, which brought together leaders from across the public and private sectors and civil society worldwide, was an opportunity to celebrate the start of this effort and learn about how WiDEF will implement its ambitious vision. Representing the Biden-Harris Administration at today’s kickoff event was Rachel Vogelstein, White House Gender Policy Council Deputy Director.

Advancing access to digital technology for all women and girls is critical to achieving the United Nations’ Sustainable Development Goals. This will help ensure that everyone has access to economic opportunities and advancement as well as government services, education, and healthcare.

In low- and middle-income countries, nearly one and a half billion women lack access to online services. Through 2022, there were 259 million more men than women globally using the internet; a gap that has cost the global economy an estimated $1 trillion. Closing the gender digital divide would increase economic activity by an estimated $524 billion by 2025.

WiDEF is administered by consortium partners CARE, Global Digital Inclusion Partnership (GDIP), and the GSMA Foundation. The consortium will collaborate with industry-leading organizations to effectively engage local and global private sector actors and funders to advance a shared set of commitments to closing the gender digital divide.

“WiDEF is about putting millions of women at the center of connectivity and information programming. CARE brings our strength in locally led, gender-centered programming in over 100 countries to the effort. The consortium’s collective focus on technology, policy, and gender advocacy offers the greatest opportunity yet to create and sustain an internet that works for the women who could most benefit from it,” said Revi Sterling, WiDEF Technical Director and CARE Senior Technical Director, Digital Inclusion.

“Launching WiDEF is indeed a special moment, one that reflects real commitment and determination to address the stubborn gender digital divide and open the possibilities for women in the digital economy. GDIP is committed to women’s digital inclusion, and we look forward to advocating alongside our global partners to advance this collective effort,” said Sonia Jorge, GDIP Executive Director.

“Closing the gender digital divide has been at the centre of the GSMA Foundation’s work for over a decade, and we are extremely honoured to play an active role in the management of the Women in the Digital Economy Fund. We now look forward to receiving applications to the first round launched today, and to the further two rounds to be announced later this year, focused on large private sector actors, and India specifically,” said Max Cuvellier Giacomelli, Head of Mobile for Development, GSMA.

WiDEF will support and fund programs that advance digital access and affordability; develop relevant products and tools; provide digital literacy and skills training; promote online safety and security; and invest in sex-disaggregated data and research. It will support, wherever possible, women-led and gender transformative solutions, products, and tools and will invest heavily in ensuring the voices and institutions closest to the gender digital divide are central to the effort.

As part of today’s event, WiDEF announced the first call for applications, inviting local institutions worldwide to apply to receive WiDEF funding and support. Applications are due by May 6, 2024.

In addition to financial support from USAID and the Bill & Melinda Gates Foundation, funding is also being provided by Microsoft and the Korean International Cooperation Agency.

To learn more, email contact@widef.global, visit us online at widef.global or follow WiDEF on social media (Instagram, Facebook, LinkedIn and Twitter/X).

About CARE
Founded in 1945 with the creation of the CARE Package®, CARE is a leading humanitarian organization fighting global poverty. CARE places special focus on working alongside women and girls. Equipped with the proper resources, women and girls have the power to lift whole families and entire communities out of poverty. This year, CARE and partners worked in 109 countries implementing 1,671 poverty-fighting development and humanitarian aid projects and initiatives that reached 167,000,000 people. To learn more, visit www.care.org.

About GDIP
The Global Digital Inclusion Partnership (GDIP) is a coalition of public, private, and civil society organizations working to bring internet connectivity to the global majority and ensure everyone is meaningfully connected by 2030. Founded by a global team of experts who successfully championed affordable and meaningful connectivity around the world, GDIP advances digital opportunities to empower and support people’s lives and agency, leading to inclusive digital societies.

GSMA Mobile for Development Foundation
The GSMA Mobile for Development Foundation, Inc. (‘The GSMA Foundation’) brings together mobile operators, innovators, governments, and the international development community to realise the positive social, economic and climate impact of mobile technology, primarily in low- and middle-income countries. With funding from donors and the GSMA, the GSMA Foundation runs programmes that advance digital and financial inclusion – with a strong focus on gender inclusivity, climate action, humanitarian response, and investment in innovative digital solutions. Since 2007, these programmes have impacted the lives of over 220 million people.

Michael de Vulpillieres
CARE
+1 929 944 1582
usa.media@care.org

GlobeNewswire Distribution ID 9062253

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

Microsoft and Quantexa announce partnership

 

Quantexa Limited

 Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos

  • Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure
  • Technology preview demonstrates Quantexa’s ambitious plan to accelerate platform, solution and generative AI adoption among business users, data, and IT professionals
  • Lighthouse customers take generative AI assistant, Q Assist™, into early adoption

LONDON, March 12, 2024 (GLOBE NEWSWIRE) — Quantexa, a global leader in decision intelligence solutions for the public and private sectors, used the backdrop of QuanCon24, its annual customer and partner conference, to reveal its Decision Intelligence Platform roadmap, and provided an update on Q Assist, a generative artificial intelligence (AI) assistant that previewed in July last year. Quantexa also announced a partnership with Microsoft. Dan Higgins, Quantexa’s Chief Product Officer, was joined by Kate Rosenshine, Global Technology Director, Strategic Partnerships at Microsoft, where they announced the immediate availability of Quantexa’s Decision Intelligence Platform on Microsoft Azure Marketplace and plans to bring a new cloud-native AI solution to mid-size banks in the United States.

Putting the Focus on Innovation and New Capabilities

Quantexa’s ambitious plan to lead the emerging decision intelligence category is anchored in helping enterprises and government agencies use contextual analytics and AI to improve organization-wide decision making. Quantexa is putting an emphasis on practical, real-world applicability today, with an eye on helping customers plan for future technology deployments. Gartner® predicts that “by 2027, 75% of new analytics content will be contextualized for intelligent applications through generative AI, enabling a composable connection between insights and actions.”*

As part of Quantexa’s growth strategy, the company showcased the platform’s ability to use AI to build a trusted data foundation and bring greater effectiveness to existing decisioning processes, while seamlessly integrating into customers’ existing technology infrastructure.

Dan Higgins, Quantexa’s Chief Product Officer, stated, “When it comes to Quantexa’s technology roadmap, we are guided by our client’s needs and leadership ambition in decision intelligence. This requires us to help our customers break down organizational silos to create a trusted data foundation, automate and augment decision making, and support continuous evaluation and improvement throughout decision processes. With the introduction of new capabilities and solutions, we remain steadfastly focused on delivering groundbreaking innovation that helps organizations protect, optimize, and grow.”

Quantexa Highlights Four Key Roadmap Pillars

  • Powering human/AI decisioning: Quantexa continues to pioneer solutions and tools to enable the use of multiple data sources and AI to automate business decision logic across various applications. Quantexa is updating its platform with enhanced workflow capabilities including new customizable scoring, alerting, and decisioning models. Quantexa debuted the platform’s new case management capabilities and an early adoption update to Q Assist, which is being deployed by customers in banking, telecommunications, and government agencies, in pilot programs to tackle financial crime, fraud, and risk, and to identify new revenue opportunities with customer intelligence.
  • Operationalizing data at scale with AI and contextual analytics: Quantexa’s ability to help customers build a trusted data foundation and gain single customer views remains a top driver of platform adoption. To meet increasing demand and unique industry complexities, Quantexa showcased advancements in data management, contextual analytics, and AI capabilities. Quantexa previewed the ability to move beyond news intelligence to support the ingestion and analysis of any unstructured data source via entity resolution and give the ability to customers to enable large-scale graph analysis and graph machine learning by combining large language models (LLMs) and knowledge graphs.
  • Accelerating time-to-value through simplified deployments and packaged solutions: Quantexa announced new options to make it easier for customers and partners to get up and running with new deployment methods, including the introduction of out-of-the box configurations as well as low-code and no-code tools. This year, Quantexa is also investing in accelerating the enablement of its growing ecosystem of partners, which includes PWC, EY, Dun & Bradstreet, KPMG, and Moody’s, who were presenting partners at QuanCon24.
  • Seamlessly integrating with customers’ existing technology stacks and processes: Quantexa’s Decision Intelligence Platform has an open and extensible architecture with scalable APIs and streamlined integrations with downstream applications and systems. Future efforts will focus on building a standardized framework and out-of-the-box connectors.

Quantexa brings its Decision Intelligence Platform and solutions to Azure with Microsoft partnership

A highlight of Quantexa’s Roadmap Session at today’s event was the announcement of Quantexa’s new partnership with Microsoft. Highlights included:

  • The immediate availability of Quantexa’s Decision Intelligence Platform on Azure Marketplace: Quantexa’s Decision Intelligence Platform is now available globally on Azure Marketplace for customers across financial services, the public sector, insurance, telecommunications, media and technology industries.
  • AI innovation aids mid-size banks in meeting regulatory and market pressures:
    Additionally, Quantexa detailed plans to build a new Azure native SaaS solution, allowing customers to deploy an end-to-end anti-money laundering (AML) transaction monitoring, investigations, and case management solution designed to take best-in-class capabilities used by the world’s largest banks into a tailored offering to meet the needs of financial services institutions that hold up to US$200B in assets. The solution will provide critical capabilities for monitoring, detecting, and investigating financial crime and risk to banks throughout the United States. The planned offering will help customers implement next generation technology, allowing them to keep up with the rapid pace of innovation and meet increasing compliance regulations. Quantexa is working with Microsoft to make an initial set of capabilities available by the end of 2024.

Dan Higgins, Chief Product Officer, Quantexa, said: Over the course of the last 12 months, decision intelligence has become a rapidly growing trend, as noted by multiple industry analysts. But decision intelligence has always been at our core since our inception. And at Quantexa, as we strive to innovate and evolve our technology offering to help enterprises and government agencies use contextual analytics and AI to improve decision making, I am thrilled to see our latest technology roadmap ring true to that. Our new partnership with Microsoft is testament to our commitment to providing our customers with accessible solutions, and we’ll continue to do more and to meet our customers where they need us.”

Tyler Pichach, Director of Financial Services Strategy at Microsoft, said: Financial Services organizations have become smarter and more efficient when it comes to successfully navigating shifting market dynamics. This is creating the need to use trusted data and AI to augment and automate the thousands of operational decisions they make daily when it comes to managing their data, tackling financial crime, or identifying new revenue opportunities. We are committed to working with partners like Quantexa to make its Decision Intelligence Platform available on Microsoft Azure Marketplace, bring new cloud native solutions to expanded market segments, and drive joint innovation to help our customers across multiple industries tackle some of their biggest challenges.”

To learn more about how your organization can put decision intelligence to work, or to read Forrester’s Total Economic Impact™ of the Quantexa Decision Intelligence Platform, visit here. To watch on-demand sessions from QuanCon24, visit the QuanCon website.

*Gartner, Predicts 2024: How Artificial Intelligence Will Impact Analytics Users, By Edgar Macari, Peter Krensky, Afraz Jaffri, David Pidsley, Aura Popa, Mike Fang, Rita Sallam, Julian Sun, Radu Miclaus, 4 January 2024.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About Quantexa
Quantexa is a global data and analytics software company, pioneering decision intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, Know Your Customer (KYC), customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90 percent more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 700 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, Dublin, Brussels, Malaga, UAE, New York, Boston, Toronto, Sydney, Melbourne, and Tokyo.

Media Inquiries

C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight
E: Quantexa@fightflight.co.uk

C: Adam Jaffe, SVP of Corporate Marketing
T: +1 609 502 6889
E: adamjaffe@quantexa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/36fa5c1e-cba8-4a4c-9272-191148c797aa

GlobeNewswire Distribution ID 1000928747

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

Microsoft and Quantexa announce partnership

 

Quantexa Limited

 Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos

  • Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure
  • Technology preview demonstrates Quantexa’s ambitious plan to accelerate platform, solution and generative AI adoption among business users, data, and IT professionals
  • Lighthouse customers take generative AI assistant, Q Assist™, into early adoption

LONDON, March 12, 2024 (GLOBE NEWSWIRE) — Quantexa, a global leader in decision intelligence solutions for the public and private sectors, used the backdrop of QuanCon24, its annual customer and partner conference, to reveal its Decision Intelligence Platform roadmap, and provided an update on Q Assist, a generative artificial intelligence (AI) assistant that previewed in July last year. Quantexa also announced a partnership with Microsoft. Dan Higgins, Quantexa’s Chief Product Officer, was joined by Kate Rosenshine, Global Technology Director, Strategic Partnerships at Microsoft, where they announced the immediate availability of Quantexa’s Decision Intelligence Platform on Microsoft Azure Marketplace and plans to bring a new cloud-native AI solution to mid-size banks in the United States.

Putting the Focus on Innovation and New Capabilities

Quantexa’s ambitious plan to lead the emerging decision intelligence category is anchored in helping enterprises and government agencies use contextual analytics and AI to improve organization-wide decision making. Quantexa is putting an emphasis on practical, real-world applicability today, with an eye on helping customers plan for future technology deployments. Gartner® predicts that “by 2027, 75% of new analytics content will be contextualized for intelligent applications through generative AI, enabling a composable connection between insights and actions.”*

As part of Quantexa’s growth strategy, the company showcased the platform’s ability to use AI to build a trusted data foundation and bring greater effectiveness to existing decisioning processes, while seamlessly integrating into customers’ existing technology infrastructure.

Dan Higgins, Quantexa’s Chief Product Officer, stated, “When it comes to Quantexa’s technology roadmap, we are guided by our client’s needs and leadership ambition in decision intelligence. This requires us to help our customers break down organizational silos to create a trusted data foundation, automate and augment decision making, and support continuous evaluation and improvement throughout decision processes. With the introduction of new capabilities and solutions, we remain steadfastly focused on delivering groundbreaking innovation that helps organizations protect, optimize, and grow.”

Quantexa Highlights Four Key Roadmap Pillars

  • Powering human/AI decisioning: Quantexa continues to pioneer solutions and tools to enable the use of multiple data sources and AI to automate business decision logic across various applications. Quantexa is updating its platform with enhanced workflow capabilities including new customizable scoring, alerting, and decisioning models. Quantexa debuted the platform’s new case management capabilities and an early adoption update to Q Assist, which is being deployed by customers in banking, telecommunications, and government agencies, in pilot programs to tackle financial crime, fraud, and risk, and to identify new revenue opportunities with customer intelligence.
  • Operationalizing data at scale with AI and contextual analytics: Quantexa’s ability to help customers build a trusted data foundation and gain single customer views remains a top driver of platform adoption. To meet increasing demand and unique industry complexities, Quantexa showcased advancements in data management, contextual analytics, and AI capabilities. Quantexa previewed the ability to move beyond news intelligence to support the ingestion and analysis of any unstructured data source via entity resolution and give the ability to customers to enable large-scale graph analysis and graph machine learning by combining large language models (LLMs) and knowledge graphs.
  • Accelerating time-to-value through simplified deployments and packaged solutions: Quantexa announced new options to make it easier for customers and partners to get up and running with new deployment methods, including the introduction of out-of-the box configurations as well as low-code and no-code tools. This year, Quantexa is also investing in accelerating the enablement of its growing ecosystem of partners, which includes PWC, EY, Dun & Bradstreet, KPMG, and Moody’s, who were presenting partners at QuanCon24.
  • Seamlessly integrating with customers’ existing technology stacks and processes: Quantexa’s Decision Intelligence Platform has an open and extensible architecture with scalable APIs and streamlined integrations with downstream applications and systems. Future efforts will focus on building a standardized framework and out-of-the-box connectors.

Quantexa brings its Decision Intelligence Platform and solutions to Azure with Microsoft partnership

A highlight of Quantexa’s Roadmap Session at today’s event was the announcement of Quantexa’s new partnership with Microsoft. Highlights included:

  • The immediate availability of Quantexa’s Decision Intelligence Platform on Azure Marketplace: Quantexa’s Decision Intelligence Platform is now available globally on Azure Marketplace for customers across financial services, the public sector, insurance, telecommunications, media and technology industries.
  • AI innovation aids mid-size banks in meeting regulatory and market pressures:
    Additionally, Quantexa detailed plans to build a new Azure native SaaS solution, allowing customers to deploy an end-to-end anti-money laundering (AML) transaction monitoring, investigations, and case management solution designed to take best-in-class capabilities used by the world’s largest banks into a tailored offering to meet the needs of financial services institutions that hold up to US$200B in assets. The solution will provide critical capabilities for monitoring, detecting, and investigating financial crime and risk to banks throughout the United States. The planned offering will help customers implement next generation technology, allowing them to keep up with the rapid pace of innovation and meet increasing compliance regulations. Quantexa is working with Microsoft to make an initial set of capabilities available by the end of 2024.

Dan Higgins, Chief Product Officer, Quantexa, said: Over the course of the last 12 months, decision intelligence has become a rapidly growing trend, as noted by multiple industry analysts. But decision intelligence has always been at our core since our inception. And at Quantexa, as we strive to innovate and evolve our technology offering to help enterprises and government agencies use contextual analytics and AI to improve decision making, I am thrilled to see our latest technology roadmap ring true to that. Our new partnership with Microsoft is testament to our commitment to providing our customers with accessible solutions, and we’ll continue to do more and to meet our customers where they need us.”

Tyler Pichach, Director of Financial Services Strategy at Microsoft, said: Financial Services organizations have become smarter and more efficient when it comes to successfully navigating shifting market dynamics. This is creating the need to use trusted data and AI to augment and automate the thousands of operational decisions they make daily when it comes to managing their data, tackling financial crime, or identifying new revenue opportunities. We are committed to working with partners like Quantexa to make its Decision Intelligence Platform available on Microsoft Azure Marketplace, bring new cloud native solutions to expanded market segments, and drive joint innovation to help our customers across multiple industries tackle some of their biggest challenges.”

To learn more about how your organization can put decision intelligence to work, or to read Forrester’s Total Economic Impact™ of the Quantexa Decision Intelligence Platform, visit here. To watch on-demand sessions from QuanCon24, visit the QuanCon website.

*Gartner, Predicts 2024: How Artificial Intelligence Will Impact Analytics Users, By Edgar Macari, Peter Krensky, Afraz Jaffri, David Pidsley, Aura Popa, Mike Fang, Rita Sallam, Julian Sun, Radu Miclaus, 4 January 2024.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About Quantexa
Quantexa is a global data and analytics software company, pioneering decision intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, Know Your Customer (KYC), customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90 percent more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 700 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, Dublin, Brussels, Malaga, UAE, New York, Boston, Toronto, Sydney, Melbourne, and Tokyo.

Media Inquiries

C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight
E: Quantexa@fightflight.co.uk

C: Adam Jaffe, SVP of Corporate Marketing
T: +1 609 502 6889
E: adamjaffe@quantexa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/36fa5c1e-cba8-4a4c-9272-191148c797aa

GlobeNewswire Distribution ID 1000928747

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

Microsoft and Quantexa announce partnership

 

Quantexa Limited

 Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos

  • Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure
  • Technology preview demonstrates Quantexa’s ambitious plan to accelerate platform, solution and generative AI adoption among business users, data, and IT professionals
  • Lighthouse customers take generative AI assistant, Q Assist™, into early adoption

LONDON, March 12, 2024 (GLOBE NEWSWIRE) — Quantexa, a global leader in decision intelligence solutions for the public and private sectors, used the backdrop of QuanCon24, its annual customer and partner conference, to reveal its Decision Intelligence Platform roadmap, and provided an update on Q Assist, a generative artificial intelligence (AI) assistant that previewed in July last year. Quantexa also announced a partnership with Microsoft. Dan Higgins, Quantexa’s Chief Product Officer, was joined by Kate Rosenshine, Global Technology Director, Strategic Partnerships at Microsoft, where they announced the immediate availability of Quantexa’s Decision Intelligence Platform on Microsoft Azure Marketplace and plans to bring a new cloud-native AI solution to mid-size banks in the United States.

Putting the Focus on Innovation and New Capabilities

Quantexa’s ambitious plan to lead the emerging decision intelligence category is anchored in helping enterprises and government agencies use contextual analytics and AI to improve organization-wide decision making. Quantexa is putting an emphasis on practical, real-world applicability today, with an eye on helping customers plan for future technology deployments. Gartner® predicts that “by 2027, 75% of new analytics content will be contextualized for intelligent applications through generative AI, enabling a composable connection between insights and actions.”*

As part of Quantexa’s growth strategy, the company showcased the platform’s ability to use AI to build a trusted data foundation and bring greater effectiveness to existing decisioning processes, while seamlessly integrating into customers’ existing technology infrastructure.

Dan Higgins, Quantexa’s Chief Product Officer, stated, “When it comes to Quantexa’s technology roadmap, we are guided by our client’s needs and leadership ambition in decision intelligence. This requires us to help our customers break down organizational silos to create a trusted data foundation, automate and augment decision making, and support continuous evaluation and improvement throughout decision processes. With the introduction of new capabilities and solutions, we remain steadfastly focused on delivering groundbreaking innovation that helps organizations protect, optimize, and grow.”

Quantexa Highlights Four Key Roadmap Pillars

  • Powering human/AI decisioning: Quantexa continues to pioneer solutions and tools to enable the use of multiple data sources and AI to automate business decision logic across various applications. Quantexa is updating its platform with enhanced workflow capabilities including new customizable scoring, alerting, and decisioning models. Quantexa debuted the platform’s new case management capabilities and an early adoption update to Q Assist, which is being deployed by customers in banking, telecommunications, and government agencies, in pilot programs to tackle financial crime, fraud, and risk, and to identify new revenue opportunities with customer intelligence.
  • Operationalizing data at scale with AI and contextual analytics: Quantexa’s ability to help customers build a trusted data foundation and gain single customer views remains a top driver of platform adoption. To meet increasing demand and unique industry complexities, Quantexa showcased advancements in data management, contextual analytics, and AI capabilities. Quantexa previewed the ability to move beyond news intelligence to support the ingestion and analysis of any unstructured data source via entity resolution and give the ability to customers to enable large-scale graph analysis and graph machine learning by combining large language models (LLMs) and knowledge graphs.
  • Accelerating time-to-value through simplified deployments and packaged solutions: Quantexa announced new options to make it easier for customers and partners to get up and running with new deployment methods, including the introduction of out-of-the box configurations as well as low-code and no-code tools. This year, Quantexa is also investing in accelerating the enablement of its growing ecosystem of partners, which includes PWC, EY, Dun & Bradstreet, KPMG, and Moody’s, who were presenting partners at QuanCon24.
  • Seamlessly integrating with customers’ existing technology stacks and processes: Quantexa’s Decision Intelligence Platform has an open and extensible architecture with scalable APIs and streamlined integrations with downstream applications and systems. Future efforts will focus on building a standardized framework and out-of-the-box connectors.

Quantexa brings its Decision Intelligence Platform and solutions to Azure with Microsoft partnership

A highlight of Quantexa’s Roadmap Session at today’s event was the announcement of Quantexa’s new partnership with Microsoft. Highlights included:

  • The immediate availability of Quantexa’s Decision Intelligence Platform on Azure Marketplace: Quantexa’s Decision Intelligence Platform is now available globally on Azure Marketplace for customers across financial services, the public sector, insurance, telecommunications, media and technology industries.
  • AI innovation aids mid-size banks in meeting regulatory and market pressures:
    Additionally, Quantexa detailed plans to build a new Azure native SaaS solution, allowing customers to deploy an end-to-end anti-money laundering (AML) transaction monitoring, investigations, and case management solution designed to take best-in-class capabilities used by the world’s largest banks into a tailored offering to meet the needs of financial services institutions that hold up to US$200B in assets. The solution will provide critical capabilities for monitoring, detecting, and investigating financial crime and risk to banks throughout the United States. The planned offering will help customers implement next generation technology, allowing them to keep up with the rapid pace of innovation and meet increasing compliance regulations. Quantexa is working with Microsoft to make an initial set of capabilities available by the end of 2024.

Dan Higgins, Chief Product Officer, Quantexa, said: Over the course of the last 12 months, decision intelligence has become a rapidly growing trend, as noted by multiple industry analysts. But decision intelligence has always been at our core since our inception. And at Quantexa, as we strive to innovate and evolve our technology offering to help enterprises and government agencies use contextual analytics and AI to improve decision making, I am thrilled to see our latest technology roadmap ring true to that. Our new partnership with Microsoft is testament to our commitment to providing our customers with accessible solutions, and we’ll continue to do more and to meet our customers where they need us.”

Tyler Pichach, Director of Financial Services Strategy at Microsoft, said: Financial Services organizations have become smarter and more efficient when it comes to successfully navigating shifting market dynamics. This is creating the need to use trusted data and AI to augment and automate the thousands of operational decisions they make daily when it comes to managing their data, tackling financial crime, or identifying new revenue opportunities. We are committed to working with partners like Quantexa to make its Decision Intelligence Platform available on Microsoft Azure Marketplace, bring new cloud native solutions to expanded market segments, and drive joint innovation to help our customers across multiple industries tackle some of their biggest challenges.”

To learn more about how your organization can put decision intelligence to work, or to read Forrester’s Total Economic Impact™ of the Quantexa Decision Intelligence Platform, visit here. To watch on-demand sessions from QuanCon24, visit the QuanCon website.

*Gartner, Predicts 2024: How Artificial Intelligence Will Impact Analytics Users, By Edgar Macari, Peter Krensky, Afraz Jaffri, David Pidsley, Aura Popa, Mike Fang, Rita Sallam, Julian Sun, Radu Miclaus, 4 January 2024.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About Quantexa
Quantexa is a global data and analytics software company, pioneering decision intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, Know Your Customer (KYC), customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90 percent more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 700 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, Dublin, Brussels, Malaga, UAE, New York, Boston, Toronto, Sydney, Melbourne, and Tokyo.

Media Inquiries

C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight
E: Quantexa@fightflight.co.uk

C: Adam Jaffe, SVP of Corporate Marketing
T: +1 609 502 6889
E: adamjaffe@quantexa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/36fa5c1e-cba8-4a4c-9272-191148c797aa

GlobeNewswire Distribution ID 1000928747

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization

Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth

DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has signed a definitive agreement to divest assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare companies.

By divesting these businesses, Fortrea aims to advance the growth strategy and solutions of Endpoint and Fortrea Patient Access, positioning them for increased investment to accelerate the technology roadmap and further enhance operations to support best-in-class customer solutions and delivery. The remaining business of Fortrea will strengthen its focus on clinical development phases 1 through 4. Closing is targeted for the second quarter of 2024, subject to customary closing conditions and regulatory approvals, as well as the parties entering into certain services and operating agreements.

“Today marks a significant milestone in Fortrea’s ongoing journey, as we sharpen our focus on organically growing as a pure-play CRO, with added financial flexibility,” said Fortrea Chairman and CEO Tom Pike. “After undertaking a strategic review of our business, divesting Endpoint and Fortrea Patient Access aligns with the interests of our customers. Arsenal has extensive experience in building businesses that create systematic improvement in health outcomes, and I am confident that Endpoint and Fortrea Patient Access will be able to strengthen their market positions, nurture top-tier talent and invest in new capabilities and resources while delivering solutions that improve patients’ lives.”

“I am excited for this next chapter for Endpoint and Fortrea Patient Access,” said Sam Osman, president of Enabling Services at Fortrea, who will serve as the CEO of these businesses with Arsenal. “These businesses will be distinctively positioned to effectively manage the patient journey across clinical trials and into commercialization by driving patient access and adherence for approved therapies. Combining Arsenal’s deep investment acumen and leading industry operational expertise, I am confident the Endpoint and Fortrea Patient Access businesses are well positioned for growth and delivery of enhanced capabilities for patients and pharma sponsors. I look forward to our continued positive impact on healthcare.”

“Endpoint and Fortrea Patient Access have a proud, decades-long track record of market leadership in supporting clinical research and commercialization of innovative therapies. Arsenal takes pride in building organizations that meaningfully improve healthcare. We are excited to partner with management and employees to accelerate the growth of these two businesses,” said Gene Gorbach, an Investment Partner of Arsenal.

Dimitris Agrafiotis, Ph.D., Director of Digital, Analytics & AI at Arsenal said, “Endpoint and Fortrea Patient Access provide essential solutions that enable patients’ participation in clinical trials and access to therapies. I am delighted to support the talented team at Endpoint and Fortrea Patient Access. Together, we will further enhance the sophistication of technology capabilities that underpin these companies’ commitment to delivering the highest quality services to the pharmaceutical industry.”

Endpoint Clinical
Endpoint operates in the high growth eClinical market as a leading provider of Randomization and Trial Supply Management (RTSM) solutions to biopharmaceutical and CRO customers with expertise in serving complex and late-stage clinical trials. For more than 15 years, Endpoint has had a successful track record of effectively supporting more than 1,750 clinical trials involving 875,000 patients across 90 countries and has cultivated a blue-chip customer base and nurtured long-standing strategic relationships.

Fortrea Patient Access
Fortrea Patient Access is a scaled leader in the HUB services and patient access market, serving the biopharmaceutical industry with comprehensive patient support, product access, affordability and adherence solutions for more than 30 years. Further advanced by its recently expanded non-commercial specialty pharmacy, FortreaRx™, to support enhanced distribution of cold-chain and ambient free goods products, Fortrea Patient Access is committed to driving patient outcomes and improving healthcare accessibility through its extensive experience while currently supporting more than 2.5 million patients and over 100 unique brands across more than 25 disease indications.

Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 290 platform and add-on acquisitions, and achieved more than 35 realizations. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.  For more information, visit www.arsenalcapital.com.

Advisors
Barclays is serving as exclusive financial advisor to Fortrea, and Smith Anderson is serving as its legal counsel. Sidley Austin LLP served as Arsenal’s legal counsel.

Earnings Call and Replay
Fortrea will discuss the divestiture announcement on its fourth quarter 2023 earnings conference call, which will be held today at 9:00 am ET. The conference can be accessed through the Fortrea Investor Relations website or the following earnings webcast link. To avoid potential delays, please join at least 10 minutes prior to the start of the call. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea website. A supplemental slide presentation will also be available on the Fortrea Investor Relations website prior to the start of the call.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, consulting services, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 18,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the anticipated benefits of the transaction, including future financial and operating performance, and the anticipated timing for completing the transaction. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “guidance,” “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results could differ materially from these forward looking statements due to a number of factors, including, but not limited to: satisfaction of the conditions precedent to consummation of the proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses transaction, including the ability to secure regulatory approvals, and the Company’s ability to complete the transaction in a timely manner or at all; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; the parties’ ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; and other factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company’s business, see the “Risk Factors” Section of the Company’s Registration Statement on Form 10, as filed with the Securities and Exchange Commission (the “SEC”), as such factors may be amended or updated from time to time in the Company’s subsequent periodic and other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included or incorporated by reference in this report and in the Company’s filings with the SEC. All forward-looking statements are made only as of the date of this report and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments.

Fortrea Contacts:
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

Arsenal Contact:
Jackie Schofield at  pro-Arsenal@prosek.com

GlobeNewswire Distribution ID 9061141

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization

Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth

DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has signed a definitive agreement to divest assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare companies.

By divesting these businesses, Fortrea aims to advance the growth strategy and solutions of Endpoint and Fortrea Patient Access, positioning them for increased investment to accelerate the technology roadmap and further enhance operations to support best-in-class customer solutions and delivery. The remaining business of Fortrea will strengthen its focus on clinical development phases 1 through 4. Closing is targeted for the second quarter of 2024, subject to customary closing conditions and regulatory approvals, as well as the parties entering into certain services and operating agreements.

“Today marks a significant milestone in Fortrea’s ongoing journey, as we sharpen our focus on organically growing as a pure-play CRO, with added financial flexibility,” said Fortrea Chairman and CEO Tom Pike. “After undertaking a strategic review of our business, divesting Endpoint and Fortrea Patient Access aligns with the interests of our customers. Arsenal has extensive experience in building businesses that create systematic improvement in health outcomes, and I am confident that Endpoint and Fortrea Patient Access will be able to strengthen their market positions, nurture top-tier talent and invest in new capabilities and resources while delivering solutions that improve patients’ lives.”

“I am excited for this next chapter for Endpoint and Fortrea Patient Access,” said Sam Osman, president of Enabling Services at Fortrea, who will serve as the CEO of these businesses with Arsenal. “These businesses will be distinctively positioned to effectively manage the patient journey across clinical trials and into commercialization by driving patient access and adherence for approved therapies. Combining Arsenal’s deep investment acumen and leading industry operational expertise, I am confident the Endpoint and Fortrea Patient Access businesses are well positioned for growth and delivery of enhanced capabilities for patients and pharma sponsors. I look forward to our continued positive impact on healthcare.”

“Endpoint and Fortrea Patient Access have a proud, decades-long track record of market leadership in supporting clinical research and commercialization of innovative therapies. Arsenal takes pride in building organizations that meaningfully improve healthcare. We are excited to partner with management and employees to accelerate the growth of these two businesses,” said Gene Gorbach, an Investment Partner of Arsenal.

Dimitris Agrafiotis, Ph.D., Director of Digital, Analytics & AI at Arsenal said, “Endpoint and Fortrea Patient Access provide essential solutions that enable patients’ participation in clinical trials and access to therapies. I am delighted to support the talented team at Endpoint and Fortrea Patient Access. Together, we will further enhance the sophistication of technology capabilities that underpin these companies’ commitment to delivering the highest quality services to the pharmaceutical industry.”

Endpoint Clinical
Endpoint operates in the high growth eClinical market as a leading provider of Randomization and Trial Supply Management (RTSM) solutions to biopharmaceutical and CRO customers with expertise in serving complex and late-stage clinical trials. For more than 15 years, Endpoint has had a successful track record of effectively supporting more than 1,750 clinical trials involving 875,000 patients across 90 countries and has cultivated a blue-chip customer base and nurtured long-standing strategic relationships.

Fortrea Patient Access
Fortrea Patient Access is a scaled leader in the HUB services and patient access market, serving the biopharmaceutical industry with comprehensive patient support, product access, affordability and adherence solutions for more than 30 years. Further advanced by its recently expanded non-commercial specialty pharmacy, FortreaRx™, to support enhanced distribution of cold-chain and ambient free goods products, Fortrea Patient Access is committed to driving patient outcomes and improving healthcare accessibility through its extensive experience while currently supporting more than 2.5 million patients and over 100 unique brands across more than 25 disease indications.

Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 290 platform and add-on acquisitions, and achieved more than 35 realizations. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.  For more information, visit www.arsenalcapital.com.

Advisors
Barclays is serving as exclusive financial advisor to Fortrea, and Smith Anderson is serving as its legal counsel. Sidley Austin LLP served as Arsenal’s legal counsel.

Earnings Call and Replay
Fortrea will discuss the divestiture announcement on its fourth quarter 2023 earnings conference call, which will be held today at 9:00 am ET. The conference can be accessed through the Fortrea Investor Relations website or the following earnings webcast link. To avoid potential delays, please join at least 10 minutes prior to the start of the call. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea website. A supplemental slide presentation will also be available on the Fortrea Investor Relations website prior to the start of the call.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, consulting services, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 18,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the anticipated benefits of the transaction, including future financial and operating performance, and the anticipated timing for completing the transaction. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “guidance,” “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results could differ materially from these forward looking statements due to a number of factors, including, but not limited to: satisfaction of the conditions precedent to consummation of the proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses transaction, including the ability to secure regulatory approvals, and the Company’s ability to complete the transaction in a timely manner or at all; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; the parties’ ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; and other factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company’s business, see the “Risk Factors” Section of the Company’s Registration Statement on Form 10, as filed with the Securities and Exchange Commission (the “SEC”), as such factors may be amended or updated from time to time in the Company’s subsequent periodic and other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included or incorporated by reference in this report and in the Company’s filings with the SEC. All forward-looking statements are made only as of the date of this report and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments.

Fortrea Contacts:
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

Arsenal Contact:
Jackie Schofield at  pro-Arsenal@prosek.com

GlobeNewswire Distribution ID 9061141

Recursion Announces Plans to Open New Office in London

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood

LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new office in London’s vibrant King’s Cross neighborhood. Set to formally open in June 2024, the site will provide Recursion and Valence Labs, the company’s artificial intelligence research engine, access to world-class talent across Europe’s rapidly growing TechBio sector and embed Recursion in a thriving innovation ecosystem of leading technology and life science companies.

“As Recursion continues to lead and define the TechBio industry, it’s critical we hire the best possible talent, much of which is located in Europe,” said Chris Gibson, Ph.D., Co-founder and CEO at Recursion. “London stood out as an ideal location given its brilliant and interdisciplinary talent across the fields of technology, biology and chemistry. It’s also the epicenter for the rapidly growing TechBio sector in Europe, where leading technology and life science companies like Google and Merck both sit within walking distance of our new Recursion site. I look forward to expanding our operations in Europe and hiring many new Recursionauts who will help us advance our mission of decoding biology to radically improve lives.”

To support Recursion’s leadership in TechBio and entry into London, the company is excited to announce the addition of Michael Bronstein, DeepMind Professor of Artificial Intelligence at Oxford University, as a Scientific Advisor. Professor Bronstein is a world leader in geometric deep learning, graph neural networks, and protein design. Professor Bronstein joins AI luminary Professor Yoshua Bengio in supporting Recursion and Valence Labs in the development of state-of-the-art AI models to support the industrialization of drug discovery.

“Recursion is leading the field in advancing cutting-edge AI research for real-world applications with the potential to radically improve lives, and I’m honoured to join them in their mission,” said Prof Michael Bronstein. “I have collaborated with Valence prior to their acquisition by Recursion, and I look forward to continuing to work with the team to advance this important work, especially as Recursion continues to grow in London.”

Recursion’s 6,700 square foot London office will be located at 3 Pancras Square, King’s Cross London. The building is part of a 67-acre redevelopment project in the heart of King’s Cross, with over 4.5 million square feet of office space. Located within a 3-minute walk from King’s Cross Station and St. Pancras International, the site offers excellent transit access. The building includes an onsite cafe, bicycle storage, showers, prayer room and mothers room. In line with Recursion’s commitment to sustainability, the building meets the requirements for an “Excellent” rating by BREEAM building standards and is linked to a site-wide district heating and cooling network that results in net-zero carbon emissions.

“The UK Government’s plan for attracting more inward investment into the UK is working. Recursion’s investment is yet another vote of confidence in the UK, our top talent and our amazing tech and life sciences industries,” said Investment Minister Lord Johnson. “I’m delighted Recursion has chosen London, and we’ll continue to do everything we can to ensure the UK remains the top choice for investments like this.”

Today, Recursion has over 500 employees with a near-equal mix of life scientists and technologists across sites in Salt Lake City, Toronto, Montréal, and the San Francisco Bay Area. Recursion’s new London office will serve as an extension of both Recursion and Valence Labs’ teams. To launch recruiting efforts for the new site, Recursion has opened multiple new roles across technology and biology functions with immediate plans to hire the first 20 people to be based out of the new London office. Recursion and Valence Labs will also host a TechBio Mixer tomorrow, March 12, at the location of its new site to celebrate the office and network with the TechBio community.

For more information on open positions and to apply, visit recursion.com/careers and valencelabs.com/careers.

About Recursion
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, chemistry and patient-centric data to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward-Looking Statements
This document contains information that includes or is based upon “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the opening of the London office and timing of such opening; the recruitment efforts and number of roles at the London office; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “could,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023. All forward-looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

GlobeNewswire Distribution ID 9060948

St Kitts and Nevis Paves the Way for its Global Citizens to “Connect, Collaborate and Celebrate” at the Investment Gateway Summit

Basseterre, March 08, 2024 (GLOBE NEWSWIRE) — The Government of St Kitts and Nevis have ushered in a new era of investing through the “Investment Gateway Summit”, calling for its economic citizens to visit their home. Global investors and high-net-worth individuals (HWNIs) can explore endless opportunities whilst being hosted by the Government.

The Prime Minister of St Kitts and Nevis, Honourable Dr. Terrance Drew, along with his Government, extends a personal invitation to citizens and investors to attend the exclusive inaugural Investment Gateway Summit from 11 to 15 May 2024.

This significant event is an opportunity for Kittian and Nevisian citizens around the world to return home to discover how the twin-island federation is utilising economic diversification to advance developments and our citizens.

This personal invitation from Honourable Dr. Drew, is an experience not to be missed to learn about the Sustainable Island State Agenda from the Government and key speakers , while connecting and building with visionary leaders, global businesspeople, and economic citizens.

During the five-day Summit, economic citizens can engage and interact with national leaders and global experts. They can also explore the natural wonders the islands have to offer, with unique premium experiences to share with the world.

Please click here to secure your exclusive spot at the Investment Gateway Summit.

What to Expect from the Summit? 

As an economic citizen, this will be your opportunity to connect with like-minded individuals in various businesses and network with businesspeople.

Economic Citizens will have the opportunity to experience firsthand what initiatives St Kitts and Nevis are engaging in and the progress of each development.

Learn about St Kitts and Nevis’ economic outlook for 2024 and beyond in addition to understanding how economic diversification can inspire change. Investment-led projects in the twin-federation and how you can become part of these exciting developments will be presented.

Gain insights into the Sustainable Island State Agenda and why it is an essential element in the “Investment Gateway Summit” in May 2024.

The Sustainable Island State Agenda key focus is on seven pillars:

1. Food security

2. Green energy transition

3. Economic diversification

4. Developing the Creative Economy

5. Post-pandemic recovery

6. Attract and support sustainable organisations

7. Extend social protection and safety for vulnerable individuals

These seven pillars form part of the Sustainable Island State Contribution (SISC), which is an exciting new investment option under the Citizenship by Investment (CBI) Programme.

The SISC is an opportunity to contribute to the development of a new nation. It’s a secure and sustainable option for savvy investors looking to make a strategic investment.

Collaborative sustainable development initiatives will nurture economic and community development and extend shared values of excellence.

“Connect, Collaborate and Celebrate” with Us 

If you’re interested in promoting your brand, business services, or exploring sponsorship opportunities, feel free to leave a comment here along with your inquiry in the contact form. We’ll promptly respond with details on available packages.

Tickets are limited – make sure to get your early bird tickets!

Attachment

Secretary of St Kitts and Nevis Citizenship by Investment Programme
Government of St Kitts and Nevis
00 (1-869) 467-1474
communications@skn-ciu.com

GlobeNewswire Distribution ID 9060634

WTA Foundation and Gates Foundation launch new campaign—Women Change the Game—to urge action on women’s health and nutrition

Campaign includes the groundbreaking WTA Foundation Global Women’s Health Fund, which aims to help at least 1 million women in its first year with an inaugural donation from WTA Tour title sponsor Hologic

St. Petersburg, Fla. and Seattle, March 08, 2024 (GLOBE NEWSWIRE) — Today, on International Women’s Day, the WTA Foundation and the Bill & Melinda Gates Foundation unveiled Women Change the Game, a new campaign uniting the power of women’s tennis and philanthropy to elevate women’s health and nutrition as a global priority. A key component of the campaign is the first-of-its-kind WTA Foundation Global Women’s Health Fund. With an inaugural donation from WTA Tour title sponsor Hologic, in its first year, the Fund will focus on a key aspect of preventive care: It aims to support at least one million women with prenatal vitamins in low- and middle-income countries where access to adequate nutrition for maternal health is limited.

“Throughout my life, tennis has given me a pathway to pursue my dreams, and I know first-hand how important it is to have access to the right health care and nutrition,” said Caroline Wozniacki, former WTA World No. 1 champion, and mother of two. “On International Women’s Day and beyond, I am proud to shine a light on women’s health and nutrition in the hopes that all women can reach their full power and potential.”

Women spend 25% more of their life in poor health than men, according to a 2024 report by the World Economic Forum. This significant health gap impacts women’s quality of life and limits their ability to engage in the workforce and earn a living for themselves and their families. And in the face of global crises—humanitarian disasters, war, and climate change—women and girls suffer the worst consequences.

“Every woman and girl deserves an equal opportunity to be her best—whether in school, at work, or on the tennis court,” said Naomi Osaka, four-time Grand Slam singles champion and new mom. “We are stepping up for women in need, because when we champion each other, we all win.”

Today, more than 1 billion women and girls lack access to the good nutrition and healthy diets they need to survive and thrive, with dire consequences for themselves and their children. Across the world, the gender nutrition gap is worsening. Women and girls are 50% more likely to suffer from malnutrition than boys and men. While the majority of expectant mothers in high-income countries take prenatal vitamins throughout their pregnancies, most women in low- and middle-income countries lack access to this simple, lifesaving resource. Prenatal vitamins provide key nutrients that dramatically reduce the risk of stillbirth, infant mortality, and babies born small and vulnerable, and they improve women’s health.

“It is unacceptable that so many women and girls don’t have access to adequate nutrition and basic care,” said Melinda French Gates, co-chair of the Bill & Melinda Gates Foundation. “The WTA Foundation was founded on the idea of equal opportunity, and that’s exactly what Women Change the Game is about. Nowhere is it more important to level the playing field than women’s health.”

Women Change the Game
Women Change the Game will engage global audiences through tennis—translating the power of elite athletes on the court into elite influence off the court—to take on some of the most pressing and urgent issues for women and girls. A critical component of the campaign is the new WTA Foundation Global Women’s Health Fund, which will mobilize resources for lifesaving women’s health and nutrition products and services that are readily available in high-income countries but are difficult to access or altogether unavailable in low- and middle-income countries.

The campaign features creative assets, including video, digital, and social content, that elevate the voices of elite women athletes in service of women’s equality and better health and nutrition for women worldwide. A series of activations across the Hologic WTA Tour will engage corporate sponsors, tournaments, philanthropic partners, athletes, and fans to raise awareness and funding for women’s health and nutrition. The campaign drives audiences to womenchangethegame.com to engage on the issues and donate.

The WTA Foundation Global Women’s Health Fund
The fundraising component of the partnership is the Global Women’s Health Fund, with the kick-off donation of $1.5 million coming from Hologic, title sponsor of the WTA Tour and one of the world’s top medical technology innovators focused on improving women’s health and well-being. Collaboration on the Fund marks the latest expansion of the WTA’s and Hologic’s comprehensive, multiyear alliance to elevate women’s well-being. The Fund leverages data insights from sources like the Hologic Global Women’s Health Index, which shows the interlocking importance of preventive care, access to adequate food and shelter, strong educational opportunities, and other critical resources for women and girls of all ages.

“Whether it’s prenatal vitamins for expectant mothers or routine screenings for breast and cervical cancers, we know that early intervention is pivotal to helping women live longer and better,” said Stephen P. MacMillan, chairman, president, and CEO of Hologic. “As the first donor to the Global Women’s Health Fund, we’re teaming up with the WTA Foundation and the Bill & Melinda Gates Foundation in urging others—businesses, foundations, governments, tennis fans—to join us in this crucial movement of improving women’s health.”

For at least the first year, every dollar raised through the Fund will be directed toward the Child Nutrition Fund, a global initiative aimed at ending child wasting led by UNICEF, with support from the U.K. government, the Children’s Investment Fund Foundation, the Bill & Melinda Gates Foundation, and other partners. UNICEF, a leader in global health and nutrition, has the worldwide footprint and local partnerships necessary to bring products and services directly into the hands of women in need around the world.

For more information about Women Change the Game and the WTA Foundation’s Global Women’s Health Fund, visit www.womenchangethegame.com.

About the WTA
Founded by Billie Jean King in 1973 on the principle of equal opportunity, the WTA is the global leader in women’s professional sports. The WTA is one of the world’s most recognizable and high-profile sports organizations, consisting of more than 1,600 players representing over 80 nations, all competing to earn WTA rankings points and prestigious tournament titles. The Hologic WTA Tour is comprised of over 70 events and four Grand Slams, spanning 30 countries and regions across six continents with a global audience of more than 1 billion. Further information on the WTA can be found at wtatennis.com.

About the WTA Foundation
Serving as the philanthropic arm of the leading women’s professional sport globally, the WTA Foundation empowers girls and women to live fully and supports our WTA communities worldwide through initiatives promoting equality, education, leadership, and health and wellness.

About the Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Co-chairs Bill Gates and Melinda French Gates and the board of trustees.

Attachments

WTA Foundation
wtacommunications@wtatennis.com

Bill & Melinda Gates Foundation
Media@gatesfoundation.org

GlobeNewswire Distribution ID 9060346

Hitachi Energy to appoint Andreas Schierenbeck as new Chief Executive Officer, Claudio Facchin to step down on June 30, 2024

Zurich, March 07, 2024 (GLOBE NEWSWIRE) — Hitachi Energy today announced that Andreas Schierenbeck will be appointed as the new Chief Executive Officer, effective July 1, 2024. Claudio Facchin, Hitachi Energy CEO, will step down at the end of June 2024. Andreas will engage with the Hitachi Energy Board, Executive Team and Claudio to ensure a smooth transition prior to the handover on July 1, 2024.

Andreas joins Hitachi Energy from HH2E, a new green-hydrogen production company, where he is currently co-founder and board member. He previously worked as CEO of Uniper from 2019 to 2021, where he launched the company’s decarbonization strategy. Prior to that he was the CEO of thyssenkrupp Elevator, where he led the transformation of the company into a global leader leveraging digital technology from 2013 to 2018. Between 1992 and 2012, Andreas held various management positions within Siemens, including President and CEO of Siemens Building Technologies in the US between 2010 and 2012 and Senior Vice President in the Siemens electric utility sector in Switzerland. He holds a Master of Science degree in Electrical Engineering from the TU Dresden and an Advanced Management Certificate from Harvard University in the US. Andreas is a German citizen.

“I would like to welcome Andreas to Hitachi Energy to lead the next phase of exciting growth for the business. I would also like to express my appreciation to Claudio for his great leadership transitioning and transforming the company over the last four years from the carve-out of ABB’s Power Grids business through the Hitachi ABB Power Grids Joint Venture (JV) into Hitachi Energy, a fully-owned subsidiary of Hitachi Group”, said Keiji Kojima, Representative Executive Officer, President & CEO of Hitachi, Ltd. “I look forward to continuing to support Hitachi Energy’s growth plan under the leadership of Andreas, and I wish Claudio all the best for the journey ahead.”

“Following a planned transition and a thorough selection process, we have appointed Andreas Schierenbeck as the successor to Claudio Facchin”, said Alistair Dormer, Chair of Hitachi Energy and Executive Vice President, Executive Officer and General Manager of Green Energy & Mobility Strategy Planning Division, Hitachi Ltd. “Claudio can be proud of his four years as CEO, and it has been a pleasure working with him during the past two years, supporting him and the Executive Team to deliver the transformation into Hitachi Energy, the leading power grids technology and solution provider. The Hitachi Energy 2030 growth plan centered around the commitment to continuously invest in innovation and partnerships to serve our customers is a solid foundation to build on, and I look forward to working with Andreas and the entire Hitachi Energy leadership team as we accelerate the delivery of the Hitachi Energy growth plan. Andreas’ experience of delivering transformational growth across sectors will help Hitachi Energy to scale growth and synergies with Hitachi.”

“It’s been an honor and a privilege to lead the transition to Hitachi Energy, working alongside the Executive Team and the entire Hitachi Energy organization across the globe”, said Claudio Facchin, CEO of Hitachi Energy. “The authentic passion and unwavering ownership of this team has been a limitless source of energy and motivation for me personally. Together with Hitachi teams, we have worked with customers and partners to advance the world’s energy system to be more sustainable, flexible and secure. The extraordinary achievements of Hitachi Energy would not have been possible without the continuous support from Hitachi Group. I look forward to onboarding Andreas, together with the Executive Team and the Board of Hitachi Energy, until the handover on July 1, 2024.”

“I am thrilled to embark on this journey as the new CEO of Hitachi Energy, steering the company towards new horizons in an era of transformation, where the demand for electricity is surging due to the rapid electrification of transport, buildings, and industries”, said Andreas Schierenbeck. “It is a profound honor to lead an experienced team so deeply committed to quality, innovation and sustainability as we help our customers and society accelerate towards a greener future. Together, we will continue to expand Hitachi Energy’s profitable business, ensuring that our collective efforts contribute significantly to a sustainable and electrified future.”

Hitachi Energy to appoint Andreas Schierenbeck as new Chief Executive Officer

About Hitachi Energy
Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. We are advancing the world’s energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. We integrate more than 150 GW of HVDC links into the power system, helping our customers enable more wind and solar. Headquartered in Switzerland, we employ more than 40,000 people in 90 countries and generate business volumes of over $10 billion USD.

https://www.hitachienergy.com
https://www.linkedin.com/company/hitachienergy
https://twitter.com/HitachiEnergy

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the business structure of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railway systems, and “Connective Industries” – connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s consolidated revenues for fiscal year 2022 (ended March 31, 2023) totaled 10,881.1 billion yen, with 696 consolidated subsidiaries and approximately 320,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.

Attachment

Global Media Relations
Hitachi Energy
media.relations@hitachienergy.com

GlobeNewswire Distribution ID 9059761

Dentsu Appoints Shirli Zelcer to Chief Data and Technology Officer

Steve Simpson joins as President, Data, Audiences and Technology; Shiva Vannavada appointed as President, Data and Technology Solutions

Shirli Zelcer

Chief Data & Technology Officer, dentsu

TOKYO, March 07, 2024 (GLOBE NEWSWIRE) — Dentsu (brand: dentsu; Head Office: Dentsu Group Inc.; Location: Tokyo; Representative: President and Global CEO Hiroshi Igarashi) today announced the appointment of Shirli Zelcer as Chief Data and Technology Officer (CDTO), sitting on dentsu’s Group Management Team. In this role, Zelcer will be responsible for all of dentsu’s client-facing data-driven, analytics and technology-enabled products and platforms, driving innovation and sustainable growth for clients.

Dentsu also announced today that Steve Simpson has been appointed as President, Data, Audiences and Technology, dentsu and Shiva Vannavada as President, Data and Technology Solutions, dentsu. Simpson will join the Global Media Practice leadership team to support the development of a winning Media Practice community that delivers continued excellence in its offering to clients, driving client growth and transformation. In his newly created role, Simpson will be responsible for the strategic planning and delivery of a globally-scaled, data-driven and technology-enabled audience platform that drives growth for clients, while Vannavada will focus on creating synergies across product and platforms, AI innovation, analytics and across Dentsu Global Services (DGS).

Zelcer brings over 20 years of experience in analytics and insights, business advisory and organizational design, AI and data science, and cloud and marketing technologies. She was most recently the Global Head of Analytics and Technology at Merkle, where she led a global division of over 5,600 practitioners across the Americas, EMEA, and APAC. In her new role at dentsu, Zelcer will be responsible to innovate the vision, roadmap, development and commercial impact of dentsu’s data and tech strategy across our three core practice areas: Media, CXM and Creative, working closer with Practice leads and Jean Lin, Global President – Global Practices, dentsu. The role will lead a newly formed team brought together from these Practice areas to drive consistency, interoperability and ultimately to deliver growth to dentsu’s clients through more unified capabilities.

Joining from Publicis, in his new role, Simpson will lead a global team of experts from across data management, identity, personalization, media activation and dynamic creative production, and partner with dentsu’s global products and platforms team to integrate and scale the platform across dentsu’s Global Practices.

Simpson will also be accountable for evolving dentsu’s global media delivery platform. Enabled by programmatic media delivery, enriched with 1st, 2nd and 3rd party data, it will leverage dentsu’s leading Merkury products suite to drive client competitiveness.

Having previously served as Global Chief Product and Technology Officer, dentsu Solutions, Vannavada’s expanded responsibilities as President, Data and Technology Solutions will include driving cross-practice and product collaboration, nurturing dentsu’s AI Connective community and leading his team to contribute to tech-enabled solutions and strategy.

“Innovation across data and technology are two of dentsu’s most critical points of differentiation, having led the market for many years in the development, adoption and application of proprietary platforms which give our clients the edge,” said Hiroshi Igarashi, President and Global CEO, dentsu. “We are very proud to appoint Shirli, Steve and Shiva into these new strategic roles which bring together our efforts across the organization, honing our capabilities and ensuring that dentsu and our clients remain at the forefront of innovation.”

The leadership of the broader Data and Tech organization at dentsu includes: Head of Product, Matt Seeley, and Sunil Rao leading Analytics, and Peter Rogers leading Data Platforms. DGS will also now report into Zelcer’s Data and Technology structure and in turn, Zelcer will report into Michael Komasinski, CEO, dentsu Americas & Global President – Data & Technology, dentsu.

Quotes:

“During her time at Merkle, Shirli brought together teams from around the world to collaborate on vital programs, ranging from data infrastructure implementation to advanced media mix modeling, personalization strategies and the development of bespoke AI solutions,” commented Michael Komasinski, CEO, dentsu Americas & Global President – Data & Technology, dentsu. “With her vast experience of successfully partnering with clients, alongside a proven ability to solve business challenges with cutting-edge technology solutions, I’m truly excited to see the impact that Shirli will have in her new expanded global role at dentsu.”

“It is a very exciting prospect to move into this new role at a time when not only is dentsu at a pivotal moment in its history, but data and technology have never evolved at a faster pace,” remarked Shirli Zelcer, Chief Data and Technology Officer, dentsu. “As a group, we have already made some big moves into AI over the last few years, but I truly see the combination of AI with dentsu proprietary and partner technologies as a major differentiator for our clients. I’m looking forward to broadening the impact I can have across dentsu and working closely with the talented leaders and teams across our tech community.”

Steve Simpson, President, Data, Audiences and Technology, dentsu, said: “I am thrilled to join dentsu at this exciting time of transformation and innovation. Data and technology are at the heart of the media industry and the integrated opportunity across Practices at dentsu in vast. I look forward to working with the talented teams throughout dentsu to build a world-class platform that will deliver value and innovation for our clients, helping them achieve their business goals.”

Shiva Vannavada, President, Data and Technology Solutions, dentsu, commented: “Since I began my journey at dentsu, we have been actively planning our future with AI and I am excited to take on this new expanded remit as we enter into what will undoubtedly be a transformational year for AI and the products and solutions we build using it. At dentsu, we don’t consider AI as a standalone technology, it is part of the fabric of our data, technology and product capabilities, ingrained into every practice and present in every agency brand. This makes us naturally more collaborative, more integrated and faster to market for our clients, and I look forward to working with teams across dentsu to break new ground in what is possible across data and tech for our clients.”

About dentsu

Dentsu is the network designed for what’s next, helping clients predict and plan for disruptive future opportunities and create new paths to growth in the sustainable economy. Taking a people-centered approach to business transformation, we use insights to connect brand, content, commerce and experience, underpinned by modern creativity. As part of Dentsu Group Inc. (Tokyo: 4324; ISIN: JP3551520004), we are headquartered in Tokyo, Japan, and our 71,000-strong employee base of dedicated professionals work across four regions (Japan, Americas, EMEA and APAC). Dentsu combines Japanese innovation with a diverse, global perspective to drive client growth and to shape society.

https://www.dentsu.com/
https://www.group.dentsu.com/en/

Contact:

Matt Cross
Phone: +442074306319
Email: matt.cross@dentsu.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cf533a57-ac1f-4ad2-87e5-340b90ec6957

GlobeNewswire Distribution ID 1000927842